Replies to post #17159 on Marker Therapeutics Inc (MRKR)

[Jimjames]

I sold out of my the majority of my long term gale in the pre market on the 29th.

Tpiv was on my radar. Lots of pros and a few cons, but arent they all?

Gale is a mess right now and with the possible failure of neuvax, dilution is the name of the game since they lost their 24m line of credit